Remyelinating drug could improve vision in patients with multiple sclerosis
Scientists uncover potential antiviral treatment for COVID-19
3 February 2021WHO expert calls for patience over sensitive Wuhan probe
3 February 2021Remyelinating drug could improve vision in patients with multiple sclerosis
A team led by a biomedical scientist at the University of California, Riverside, reports a drug—an estrogen receptor ligand called indazole chloride (IndCl)—has the potential to improve vision in patients with multiple sclerosis, or MS.
